RxDoctor Payments Data

Adeline Narcisse, APRN

Nurse Practitioner · Port Saint Lucie, FLNPI 1205581931

Payments from drug & device makers

$762in general payments, 2019–2025

Across 27 payments — averaging $28.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$254
  • Astellas Pharma US Inc$200
  • Sumitomo Pharma America, Inc.$85
  • Coloplast$56
  • Medtronic$36
  • 180 Medical, Inc.$30
  • plus $101 from 5 others

What the payments were for

  • Food & beverage$56274%
  • Education$20026%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$762 in reported general payments places this provider in the 70th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Medicare billing

Part B allowed, 2024
$97,832
Medicare patients
317
Services billed
2,091

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron172$122,976
MyrbetriqMirabegron77$60,119
Estradiol209$12,781
PremarinEstrogens, Conjugated18$4,868
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst191$2,119
NitrofurantoinNitrofurantoin Macrocrystal64$1,541
Cephalexin218$1,280
Fosfomycin Tromethamine11$1,183
Methenamine Hippurate11$1,039
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav103$691
Trimethoprim15$505
Ciprofloxacin Hcl109$429
Clobetasol Propionate22$266
Fluconazole53$184
Levofloxacin45$156

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$85$122,976172 claims
Astellas Pharma US IncMyrbetriq$200$60,11977 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Port Saint Lucie

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →